G1 Therapeutics Stock Market Value

GTHX Stock  USD 4.32  0.15  3.36%   
G1 Therapeutics' market value is the price at which a share of G1 Therapeutics trades on a public exchange. It measures the collective expectations of G1 Therapeutics investors about its performance. G1 Therapeutics is trading at 4.32 as of the 28th of March 2024; that is -3.36% down since the beginning of the trading day. The stock's open price was 4.47.
With this module, you can estimate the performance of a buy and hold strategy of G1 Therapeutics and determine expected loss or profit from investing in G1 Therapeutics over a given investment horizon. Check out G1 Therapeutics Correlation, G1 Therapeutics Volatility and G1 Therapeutics Alpha and Beta module to complement your research on G1 Therapeutics.
For more information on how to buy GTHX Stock please use our How to Invest in G1 Therapeutics guide.
Symbol

G1 Therapeutics Price To Book Ratio

Is G1 Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of G1 Therapeutics. If investors know GTHX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about G1 Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of G1 Therapeutics is measured differently than its book value, which is the value of GTHX that is recorded on the company's balance sheet. Investors also form their own opinion of G1 Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is G1 Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because G1 Therapeutics' market value can be influenced by many factors that don't directly affect G1 Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between G1 Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if G1 Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, G1 Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

G1 Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to G1 Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of G1 Therapeutics.
0.00
02/27/2024
No Change 0.00  0.0 
In 31 days
03/28/2024
0.00
If you would invest  0.00  in G1 Therapeutics on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding G1 Therapeutics or generate 0.0% return on investment in G1 Therapeutics over 30 days. G1 Therapeutics is related to or competes with NMI Holdings, Primerica, Bank of New York, Assurant, US Global, Silvercrest Asset, and Kinsale Capital. G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercial... More

G1 Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure G1 Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess G1 Therapeutics upside and downside potential and time the market with a certain degree of confidence.

G1 Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for G1 Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as G1 Therapeutics' standard deviation. In reality, there are many statistical measures that can use G1 Therapeutics historical prices to predict the future G1 Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of G1 Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.275.3915.61
Details
Intrinsic
Valuation
LowRealHigh
0.183.5213.74
Details
Naive
Forecast
LowNextHigh
0.083.9814.20
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.244.404.55
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as G1 Therapeutics. Your research has to be compared to or analyzed against G1 Therapeutics' peers to derive any actionable benefits. When done correctly, G1 Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in G1 Therapeutics.

G1 Therapeutics Backtested Returns

G1 Therapeutics is dangerous given 3 months investment horizon. G1 Therapeutics retains Efficiency (Sharpe Ratio) of 0.12, which attests that the company had a 0.12% return per unit of price deviation over the last 3 months. We have analyze and collected data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.19% are justified by taking the suggested risk. Use G1 Therapeutics Semi Deviation of 10.69, market risk adjusted performance of 0.1852, and Standard Deviation of 9.92 to evaluate company specific risk that cannot be diversified away. G1 Therapeutics holds a performance score of 9 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of 7.02, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, G1 Therapeutics will likely underperform. Use G1 Therapeutics value at risk, and the relationship between the information ratio and kurtosis , to analyze future returns on G1 Therapeutics.

Auto-correlation

    
  0.10  

Insignificant predictability

G1 Therapeutics has insignificant predictability. Overlapping area represents the amount of predictability between G1 Therapeutics time series from 27th of February 2024 to 13th of March 2024 and 13th of March 2024 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of G1 Therapeutics price movement. The serial correlation of 0.1 indicates that less than 10.0% of current G1 Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient0.1
Spearman Rank Test0.01
Residual Average0.0
Price Variance0.24

G1 Therapeutics lagged returns against current returns

Autocorrelation, which is G1 Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting G1 Therapeutics' stock expected returns. We can calculate the autocorrelation of G1 Therapeutics returns to help us make a trade decision. For example, suppose you find that G1 Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

G1 Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If G1 Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if G1 Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in G1 Therapeutics stock over time.
   Current vs Lagged Prices   
       Timeline  

G1 Therapeutics Lagged Returns

When evaluating G1 Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of G1 Therapeutics stock have on its future price. G1 Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, G1 Therapeutics autocorrelation shows the relationship between G1 Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in G1 Therapeutics.
   Regressed Prices   
       Timeline  

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards G1 Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, G1 Therapeutics' short interest history, or implied volatility extrapolated from G1 Therapeutics options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether G1 Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of G1 Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of G1 Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on G1 Therapeutics Stock:
Check out G1 Therapeutics Correlation, G1 Therapeutics Volatility and G1 Therapeutics Alpha and Beta module to complement your research on G1 Therapeutics.
For more information on how to buy GTHX Stock please use our How to Invest in G1 Therapeutics guide.
Note that the G1 Therapeutics information on this page should be used as a complementary analysis to other G1 Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for GTHX Stock analysis

When running G1 Therapeutics' price analysis, check to measure G1 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy G1 Therapeutics is operating at the current time. Most of G1 Therapeutics' value examination focuses on studying past and present price action to predict the probability of G1 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move G1 Therapeutics' price. Additionally, you may evaluate how the addition of G1 Therapeutics to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Money Managers
Screen money managers from public funds and ETFs managed around the world
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
G1 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of G1 Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of G1 Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...